Pterostilbene inhibits dimethylnitrosamine-induced liver fibrosis in rats.
Ming-Fen Lee, Min-Lung Liu, An-Chin Cheng, Mei-Ling Tsai, Chi-Tang Ho, Wen-Shiung Liou, Min-Hsiung Pan
Index: Food Chem. 138(2-3) , 802-7, (2013)
Full Text: HTML
Abstract
Pterostilbene, found in grapes and berries, exhibits pleiotropic effects, including anti-inflammatory, antioxidant, and anti-proliferative activities. This study was conducted to investigate the effect of pterostilbene on liver fibrosis and the potential underlying mechanism for such effect. Sprague-Dawley rats were intraperitoneally given dimethyl n-nitrosamine (DMN) (10mg/kg) 3 days per week for 4 weeks. Pterostilbene (10 or 20mg/kg) was administered by oral gavage daily. Liver function, morphology, histochemistry, and fibrotic parameters were examined. Pterostilbene supplementation alleviated the DMN-induced changes in the serum levels of alanine transaminase and aspartate transaminase (p<0.05). Fibrotic status and the activation of hepatic stellate cells were improved upon pterostilbene supplementation as evidenced by histopathological examination as well as the expression of α-smooth muscle actin (α-SMA), transforming growth factor-β1 (TGF-β1), and matrix metalloproteinase 2 (MMP2). These data demonstrated that pterostilbene exhibited hepatoprotective effects on experimental fibrosis, potentially by inhibiting the TGF-β1/Smad signaling.Copyright © 2012 Elsevier Ltd. All rights reserved.
Related Compounds
Related Articles:
2013-02-01
[Zhongguo Zhong Yao Za Zhi 38(3) , 391-6, (2013)]
2014-12-01
[J. Water Health 12(4) , 736-46, (2014)]
Developing structure-activity relationships for the prediction of hepatotoxicity.
2010-07-19
[Chem. Res. Toxicol. 23 , 1215-22, (2010)]
A predictive ligand-based Bayesian model for human drug-induced liver injury.
2010-12-01
[Drug Metab. Dispos. 38 , 2302-8, (2010)]
2015-04-01
[Regul Toxicol Pharmacol 71(3) , 529-40, (2015)]